Funder: National Institutes of Health

Due Dates: May 7, 2025 (AIDS) | June 5, 2025 (New) | July 5, 2025 (Renewal/Resubmission/Revision) | September 7, 2025 (AIDS) | October 5, 2025 (New) | November 5, 2025 (Renewal/Resubmission/Revision) | January 7, 2026 (AIDS) | and standard NIH cycles through January 7, 2028

Funding Amounts: No budget cap; budgets must reflect actual project needs. Up to 4 years for most, 5 years for Early-Stage Investigators. One renewal allowed.

Summary: Supports development of innovative technologies (not clinical trials) that enable acquisition of biomedical knowledge and advance the state of the art for broad biomedical research use.

Key Information: Applications must focus solely on technology development (not biological questions); clinical trials are not allowed.